CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 93  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0751
LYS 10.0161
GLU 20.0068
LEU 30.0179
ARG 40.0143
CYS 50.0070
GLN 60.0220
CYS 70.0049
ILE 80.0129
LYS 90.0087
THR 100.0152
TYR 110.0056
SER 120.0235
LYS 130.0437
PRO 140.0175
PHE 150.0086
HIS 160.0129
PRO 170.0047
LYS 180.0141
PHE 190.0075
ILE 200.0039
LYS 210.0137
GLU 220.0096
LEU 230.0167
ARG 240.0105
VAL 250.0125
ILE 260.0277
GLU 270.0230
SER 280.0079
GLY 290.0367
PRO 300.0169
HIS 310.0094
CYS 320.0180
ALA 330.0170
ASN 340.0102
THR 350.0149
GLU 360.0170
ILE 370.0167
ILE 380.0123
VAL 390.0058
LYS 400.0127
LEU 410.0188
SER 420.0263
ASP 430.0281
GLY 440.0152
ARG 450.0222
GLU 460.0253
LEU 470.0113
CYS 480.0058
LEU 490.0075
ASP 500.0280
PRO 510.0249
LYS 520.0450
GLU 530.0439
ASN 540.0421
TRP 550.0180
VAL 560.0193
GLN 570.0182
ARG 580.0299
VAL 590.0063
VAL 600.0123
GLU 610.0256
LYS 620.0170
PHE 630.0119
LEU 640.0155
LYS 650.0403
ARG 660.0078
ALA 670.0102
GLU 680.0266
ASN 690.0751

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.